[Hiring] Associate Director, HCP Marketing @Dyne Therapeutics

Role Description

The Associate Director, DMD HCP Marketing, plays a key role in developing and executing HCP-focused strategies and initiatives that empower care providers who treat Duchenne muscular dystrophy. In an active launch environment, this role will lead key HCP education platforms, including peer-to-peer programming and commercial congress strategy, while supporting broader HCP launch execution and omnichannel activation. The role blends strategic thinking with strong executional ownership, ensuring Dyne delivers meaningful engagement and education aligned with our mission and brand objectives.

• Operate with agility to meet critical launch milestones.
• Leverage innovative technologies and omnichannel tactics to maximize educational impact.
• Partner closely across Marketing, Medical Affairs, Scientific Affairs, Market Access, and Field Teams to create a cohesive HCP experience from awareness through treatment.
• Continuously optimize based on real-time insights and launch KPIs.

Qualifications

• Bachelor’s degree required; advanced degree such as MBA or MPH preferred.
• 7+ years of experience in pharmaceutical or biotechnology marketing, with meaningful experience in US HCP Marketing.
• Experience supporting or leading launch-phase HCP marketing initiatives for specialty or rare disease products.
• Experience in neurology, neuromuscular, rare disease, or accelerated approval strongly preferred.
• Proven ability to translate complex science into compelling, compliant HCP messaging.
• Strong strategic mindset with hands-on execution capability.
• Experience working in cross-functional teams in a fast-paced environment.
• Excellence in communication, influence, and stakeholder management skills.
• Entrepreneurial mindset with comfort building capabilities in a first-launch environment.
• Curious, early adopter of emerging technologies; comfortable piloting AI-enabled solutions to improve marketing effectiveness and efficiency.
• Willingness to travel as needed (anticipated up to 30%).

Requirements

• Support development of the DMD HCP strategy and lead execution of priority HCP initiatives from pre-launch through launch and beyond, in alignment with brand strategy set by the Brand Lead.
• Contribute to HCP segmentation and priority behavior mapping across stages of adoption; translate insights into sequenced engagement strategies.
• Translate clinical data and label information into HCP message strategy and content priorities.
• Provide HCP marketing input into evidence planning discussions.
• Lead execution of HCP omnichannel engagement initiatives across personal and non-personal promotion.
• Partner to build closed-loop deployment models to continuously test and learn which messages and channels resonate.
• Support the generation of actionable signals that drive next best actions across digital and field channels.
• Serve as a core member of the US Marketing Team, partnering closely with various departments.
• Contribute to competitive readiness and scenario planning.
• Lead the peer-to-peer education workstream, including strategy, execution, and ongoing optimization.
• Partner with Thought Leader Liaisons (TLLs) for peer-to-peer programming and KOL engagement.
• Lead the commercial HCP congress strategy workstream for priority meetings.
• Serve as a scientifically fluent, analytically rigorous HCP marketing partner.
• Partner with agencies and internal teams to develop and deploy high performing content.
• Drive PRC execution for HCP materials and ensure all initiatives meet regulatory, privacy and company policy requirements.

Benefits

• MA Pay Range: $195,000 - $225,000 USD.
• The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting.
• Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.

Company Description

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations.

At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities.